We checked the PD-L1 mRNA expression of genetically engineered murine thyroid cancer lines (3601R, 3868, 3743 and 3403) at baseline and in response to PLX720, IFN-γ, or both. This evidence concerns the gene IFNG and thyroid gland carcinoma.